StockClub

NNBP

NNBPNanobac Pharmaceuticals, Incorporated$ --
Nanobac Pharmaceuticals, Incorporated

Nanobac Pharmaceuticals, Incorporated

NNBP

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2007FY2007 Q4
Revenue
0M USD
YoY +86.6%
Operating Income
1M USD
YoY -37.6%
Net Income
-1M USD
YoY +37.4%
EPS
0$
YoY +100.0%

Revenue

$17,621
FY2006 Q1$161,286
$161,286
Q1
FY2006 Q2$198,851
$198,851
Q2
FY2006 Q3$222,745
$222,745
Q3
FY2006 Q4$225,086
$225,086
Q4
FY2007 Q1$5,012
$5,012
Q1
FY2007 Q2$7,444
$7,444
Q2
FY2007 Q3$13,253
$13,253
Q3
FY2007 Q4$17,621
$17,621
Q4
Actual
$-207,465 (-92.2%)

Net Income

$-6.6M
FY2006 Q1$-1.5M
$-1.5M
Q1
FY2006 Q2$-2.3M
$-2.3M
Q2
FY2006 Q3$-3.1M
$-3.1M
Q3
FY2006 Q4$-5M
$-5M
Q4
FY2007 Q1$-3.9M
$-3.9M
Q1
FY2007 Q2$-4.6M
$-4.6M
Q2
FY2007 Q3$-5.4M
$-5.4M
Q3
FY2007 Q4$-6.6M
$-6.6M
Q4
Actual
$-1.6M (-32.2%)

Surprise History

Actual RevenueAnalyst Estimate
FY2002
Actual:$11,555
FY2002
$11,555
FY2003
Actual:$482,815
FY2003
$482,815
FY2004
Actual:$358,361
FY2004
$358,361
FY2005
Actual:$656,802
FY2005
$656,802
FY2006
Actual:$225,086
FY2006
$225,086
FY2007
Actual:$17,621
FY2007
$17,621

Analyst Estimates

No forecast data